These products are used as lubricant eye drops and are being recalled out of an abundance of caution due to a risk for bacterial and fungal contamination.
All articles by Brian Park, PharmD
Donanemab is an investigational antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.
The approval was based on data from two phase 3 studies, which included patients 12 years of age and older with nonsegmental vitiligo who had depigmented areas.
Eli-cel is an investigational one-time gene therapy designed to add functional copies of the ABCD1 gene into a patient’s own hematopoietic stem cells.
Tlando is supplied as 112.5mg of testosterone undecanoate capsules.
The application included data from the phase 2 BEYOND study.
The EMPRISE study assessed the efficacy and safety of empagliflozin use in approximately 500,000 adults with type 2 diabetes.
The FDA extended the action date by 3 months to allow more time to review additional analyses of data from the Company’s clinical studies.
The study enrolled women who completed the 24-week LIBERTY 1 and 2 studies and the 28-week open-label extension studies, and who met the definition of a responder.
Byooviz (ranibizumab-nuna) is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.
-
Latest News Your top articles for Monday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses